Unlock stock picks and a broker-level newsfeed that powers Wall Street.

3 Global Stocks Estimated To Be Up To 21.5% Below Intrinsic Value

In This Article:

In the wake of heightened global trade tensions and significant market declines, investors are navigating a complex landscape marked by uncertainty and volatility. Despite these challenges, opportunities may exist in stocks that appear undervalued relative to their intrinsic value, offering potential for long-term growth as markets stabilize.

Top 10 Undervalued Stocks Based On Cash Flows

Name

Current Price

Fair Value (Est)

Discount (Est)

Suzhou TFC Optical Communication (SZSE:300394)

CN¥63.56

CN¥126.06

49.6%

Micro Systemation (OM:MSAB B)

SEK48.90

SEK97.74

50%

Mandom (TSE:4917)

¥1228.00

¥2452.46

49.9%

Aoyama Zaisan Networks CompanyLimited (TSE:8929)

¥1640.00

¥3266.59

49.8%

Zinzino (OM:ZZ B)

SEK139.80

SEK278.41

49.8%

LPP (WSE:LPP)

PLN15365.00

PLN30699.29

49.9%

América Móvil. de (BMV:AMX B)

MX$14.50

MX$28.72

49.5%

Fervi (BIT:FVI)

€14.70

€29.13

49.5%

Qi An Xin Technology Group (SHSE:688561)

CN¥28.10

CN¥55.82

49.7%

TORIDOLL Holdings (TSE:3397)

¥3718.00

¥7379.94

49.6%

Click here to see the full list of 477 stocks from our Undervalued Global Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Fertiglobe

Overview: Fertiglobe plc is a global producer and seller of nitrogen-based products with a market capitalization of AED17.68 billion.

Operations: The company's revenue is primarily derived from the production and marketing of owned produced volumes, totaling $1.90 billion, with an additional $113 million from third-party trading.

Estimated Discount To Fair Value: 21.5%

Fertiglobe is trading at AED2.13, significantly below its fair value estimate of AED2.71, indicating it may be undervalued based on discounted cash flows. Despite revenue growth forecasts of 6.9% annually and strong earnings growth expectations of 16%, interest payments are not well covered by earnings, and profit margins have declined from last year. Recent financials show a decrease in annual sales and net income, with dividends totaling USD 275 million for the year ended December 2024.

ADX:FERTIGLB Discounted Cash Flow as at Apr 2025
ADX:FERTIGLB Discounted Cash Flow as at Apr 2025

Angelalign Technology

Overview: Angelalign Technology Inc. is an investment holding company that researches, develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China with a market cap of HK$9.44 billion.

Operations: The company's revenue is primarily derived from its Dental Equipment & Supplies segment, totaling $268.79 million.

Estimated Discount To Fair Value: 12.8%